跳至主要内容
临床试验/CTRI/2024/05/066815
CTRI/2024/05/066815尚未招募4 期

A Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Meet Shilajeet Supplement on Improving Vitality, Boosting stamina, Strength and Performance in Healthy Adults. - NI

Herbal Creations0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Healthy male adult subjects age between 18–45 years.
  • 2) Participants with a body mass index (BMI) of 18.5–29.9 kg/m2
  • 3) Willing to participate in an exercise program 2-3 times per week for 8 weeks.
  • 4) Subjects should be available for duration of study period (8 weeks).
  • 5) Express a willingness to actively participate in the study and provide informed consent.

排除标准

  • 1) Individuals currently undertaking resistance training exercise.
  • 2) Clinically significant medical conditions, including but not limited to cardiovascular, neurological, psychiatric, renal, immunological, endocrine (such as uncontrolled diabetes or
  • thyroid disease), or haematological abnormalities.
  • 3) Taking medication with corticosteroids, antidepressants, anticholinergics, or any other drugs that may have influenced the study outcome.
  • 4) Severe pulmonary dysfunction (uncontrolled bronchial asthma and/or chronic obstruction).
  • 5) History of orthopaedic conditions or surgeries that would interfere with exercise performance.
  • 6) Completed any other clinical trial within 6 months prior to enrolment.
  • 7) Consumed any dietary supplements or herbal drugs within 7 days prior to screening.
  • 8) Known hypersensitivity to herbal drugs, nutritional supplements, or foods.
  • 9) Active smokers or having a history of high alcohol intake (2 standard drinks per day)

研究者

发起方
Herbal Creations

相似试验